Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death

Food Chem Toxicol. 2015 Apr:78:10-6. doi: 10.1016/j.fct.2015.01.017. Epub 2015 Feb 2.

Abstract

Studies analyzing the impact of natural antioxidants (NA) on Endothelial Cells (ECs) have dramatically increased during the last years, since a deregulated ECs redox state is at the base of the onset and progression of several cardiovascular diseases. However, whether NA can provide cardiovascular benefits is still a controversial area of debate. Resveratrol (RES), a natural polyphenol found in grapes, is believed to provide cardiovascular benefits by virtue of its antioxidant effect on the endothelium. Here, we report that tissue-attainable doses of resveratrol increased the intracellular oxidative state, thus affecting mitochondrial membrane depolarization and inducing EC death. Cyclosporine A, a mitochondrial permeability transition pore inhibitor, prevented oxidative-mediated cell death, thus implicating mitochondria in resveratrol-induced EC impairment. The specific cytochrome P450 (CYP) 2C9 inhibitor, sulfaphenazole, counteracted both oxidative stress and mitochondrial membrane depolarization, providing EC protection against resveratrol-elicited pro-oxidant effects. Our findings strongly suggest that CYP2C9 mediates resveratrol-induced oxidative stress leading to mitochondria impairment and EC death.

Keywords: Antioxidants; Cell damage; Endothelial cells; Pro-oxidant effect; Resveratrol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Death / drug effects
  • Cell Survival / drug effects
  • Cyclosporine / pharmacology
  • Cytochrome P-450 CYP2C9 / metabolism
  • Cytochrome P-450 CYP2C9 Inhibitors / pharmacology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondrial Membrane Transport Proteins / antagonists & inhibitors
  • Mitochondrial Membranes / drug effects*
  • Mitochondrial Permeability Transition Pore
  • Oxidative Stress / drug effects*
  • Reactive Oxygen Species / metabolism
  • Resveratrol
  • Stilbenes / pharmacology*
  • Sulfaphenazole / pharmacology

Substances

  • Cytochrome P-450 CYP2C9 Inhibitors
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Reactive Oxygen Species
  • Stilbenes
  • Sulfaphenazole
  • Cyclosporine
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Resveratrol